NEW YORK (GenomeWeb News) — Beckman Coulter today said first-quarter revenues increased 8 percent as R&D spending rose 6 percent and profit grew 12 percent.
 
Total receipts for the three months ended March 31 increased to $613.6 million from $569 million year over year.
 
Product-related revenue increased 8 percent to $512.4 million while service-related revenue was up 6 percent to $101.2 million. Sales of consumables grew by nearly 13 percent, the company said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.